FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

108594006: Epoprostenol sodium (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
173128019 Epoprostenol sodium en Synonym Active Entire term case insensitive SNOMED CT core module
602513018 Epoprostenol sodium (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Epoprostenol sodium Is a Product containing epoprostenol false Inferred relationship Existential restriction modifier
Epoprostenol sodium Is a Epoprostenol false Inferred relationship Existential restriction modifier
Epoprostenol sodium Is a Prostacyclin PGI2 true Inferred relationship Existential restriction modifier
Epoprostenol sodium Is modification of Epoprostenol true Inferred relationship Existential restriction modifier
Epoprostenol sodium Has disposition Platelet aggregation inhibitor true Inferred relationship Existential restriction modifier
Epoprostenol sodium Is a Substance with platelet aggregation inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Epoprostenol sodium 0.5mg/vial powder Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol sodium 1.5mg/vial powder Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent for infusion vial Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500micrograms powder and solvent for infusion vial Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Product containing precisely epoprostenol (as epoprostenol sodium) 1.5 milligram/1 vial powder for conventional release solution for injection Has precise active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier 1
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection Has precise active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier 1
Product containing precisely epoprostenol (as epoprostenol sodium) 1.5 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier 1
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion (clinical drug) Has precise active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier 1
Product containing precisely epoprostenol (as epoprostenol sodium) 1.5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier 1
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier 1
Epoprostenol 500micrograms powder and solvent for infusion vial Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent for infusion vial Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials (Advanz Pharma) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 500microgram powder and solvent for solution for injection vials (GlaxoSmithKline) Has active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent for solution for injection vials (GlaxoSmithKline) Has active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder (pH12) for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder (pH12) for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder (pH12) for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder (pH12) for solution for infusion vials (Sun Pharmaceutical Industries Europe B.V.) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol sodium 500microgram powder and solvent for solution for injection vials 1 vial Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol sodium 1.5mg powder and solvent for solution for injection vials 1 vial Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 500microgram powder and solvent for solution for injection vials (GlaxoSmithKline) 1 vial Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent for solution for injection vials (GlaxoSmithKline) 1 vial Has active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 500microgram powder and solvent for solution for injection vials (GlaxoSmithKline) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 500microgram powder and solvent for solution for injection vials (GlaxoSmithKline) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500micrograms powder and solvent for infusion vial Has specific active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol sodium 500microgram powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent for solution for injection vials (GlaxoSmithKline) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol sodium 1.5mg powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent for infusion vial Has specific active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent for solution for injection vials (GlaxoSmithKline) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder for solution for infusion vials Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder for solution for infusion vials Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Veletri 500microgram powder for solution for infusion vials (Janssen-Cilag Ltd) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Veletri 1.5mg powder for solution for infusion vials (Janssen-Cilag Ltd) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder for solution for infusion vials 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder for solution for infusion vials 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Veletri 500microgram powder for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Veletri 1.5mg powder for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent for solution for infusion vials (Sandoz Ltd) Has active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent for solution for infusion vials (Sandoz Ltd) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent for solution for infusion vials (Sandoz Ltd) Has active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent for solution for infusion vials (Sandoz Ltd) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent for solution for infusion vials (Sandoz Ltd) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent for solution for infusion vials (Sandoz Ltd) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH12) for solution for infusion vials Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent (pH12) for solution for infusion vials Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 500microgram powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent (pH12) for solution for infusion vials 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH12) for solution for infusion vials 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Flolan 500microgram powder and solvent (pH12) for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials Has specific active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent (pH10.5) for solution for infusion vials Has specific active ingredient False Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 1.5mg powder and solvent (pH10.5) for solution for infusion vials Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier
Epoprostenol 500microgram powder and solvent (pH10.5) for solution for infusion vials Has specific active ingredient True Epoprostenol sodium Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start